Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

DAPA-LVH - Does Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes?

Trial Profile

DAPA-LVH - Does Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes?

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dapagliflozin (Primary)
  • Indications Left ventricular hypertrophy; Type 2 diabetes mellitus
  • Focus Proof of concept; Therapeutic Use
  • Acronyms DAPA-LVH
  • Most Recent Events

    • 01 Sep 2020 Results of a substudy assessing whether Dapagliflozin treatment improves Left Ventricular myocardial longitudinal function and Left Ventricular diastolic function in patients with T2DM and LVH, presented at the ESC Congress 2020 Annual Congress of the European Society of Cardiology
    • 24 Jun 2020 Results published in the European Heart Journal
    • 18 Nov 2019 Primary endpoint (Change in left ventricular (LV) Mass by Cardiac MRI at 52 weeks) has been met.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top